نتایج جستجو برای: pancreatic targeting

تعداد نتایج: 231256  

Journal: :Cancer research 2008
Chitta Ranjan Patra Resham Bhattacharya Enfeng Wang Aaron Katarya Julie S Lau Shamit Dutta Michael Muders Shanfeng Wang Sarah A Buhrow Stephanie L Safgren Michael J Yaszemski Joel M Reid Matthew M Ames Priyabrata Mukherjee Debabrata Mukhopadhyay

One of the key challenges in anticancer therapy is the toxicity and poor bioavailability of the anticancer drugs. Nanotechnology can play a pivotal role by delivering drugs in a targeted fashion to the malignant cells that will reduce the systemic toxicity of the anticancer drug. In this report, we show a stepwise development of a nanoparticle-based targeted delivery system for in vitro and in ...

2015
Kaja Lund Jennifer L. Dembinski Nina Solberg Alfonso Urbanucci Ian G. Mills Stefan Krauss

BACKGROUND Pancreatic adenocarcinoma is a lethal disease with 5-year survival of less than 5%. 5-fluorouracil (5-FU) is a principal first-line therapy, but treatment only extends survival modestly and is seldom curative. Drug resistance and disease recurrence is typical and there is a pressing need to overcome this. To investigate acquired 5-FU resistance in pancreatic adenocarcinoma, we establ...

2014
Jeremy S. Wilson Romano C. Pirola Minoti V. Apte

Pancreatic cancer is a devastating disease with an unacceptably high mortality to incidence ratio. Traditional therapeutic approaches such as surgery in combination with chemo- or radiotherapy have had limited efficacy in improving the outcome of this disease. Up until just under a decade ago, the prominent desmoplastic reaction which is a characteristic of the majority of pancreatic ductal ade...

2015
Jai-Hee Moon Jae-Sik Shin Seung-Woo Hong Soo-A Jung Ih-Yeon Hwang Jeong Hee Kim Eun Kyoung Choi Seung-Hee Ha Jin-Sun Kim Kyoung-Mok Kim Dae-Won Hong Daejin Kim Yeong Seok Kim Jeong Eun Kim Kyu-Pyo Kim Yong Sang Hong Eun Kyung Choi Jung Shin Lee Maureen Hattersley Dong-Hoon Jin Tae Won Kim

Inhibitor of apoptosis proteins (IAPs) plays an important role in controlling cancer cell survival. IAPs have therefore attracted considerable attention as potential targets in anticancer therapy. In this study, we investigated the anti-tumor effect of AZD5582, a novel small-molecule IAP inhibitor, in human pancreatic cancer cells. Treating human pancreatic cancer cells with AZD5582 differentia...

2012
Yong-ping Liu Yang Ling Yue-di Hu Ying-ze Kong Feng Wang Peng Li

Resistance to gemcitabine is the major problem in pancreatic cancer chemotherapy, and recent evidence suggests that down-regulation of hTERT mRNA could enhance the antitumor efficacy of other well known chemotherapy agents targeting DNA. The aim of this study was to evaluate the combined antitumor efficacy of antisense oligonucleotides (AS-ODN) targeting hTERT mRNA and gemcitabine in human panc...

2016
Bridget A. Quinn Si Wang Elisa Barile Swadesh K. Das Luni Emdad Devanand Sarkar Surya K. De Susan Morvaridi Kharagh John L. Stebbins Stephen J. Pandol Paul B. Fisher Maurizio Pellecchia

First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine. In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a significant clinical benefit. However, in most patients, low expression of gemcitabine transporters l...

2016
Cheng Wang Biao Liu Xuelian Xu Bo Zhuang Hongxia Li Jiaqi Yin Mengyi Cong Wei Xu Aiping Lu

Chemoresistance is the major impediment for treating pancreatic cancer. Herb-derived compound triptolide (TP) can inhibit proliferation of chemo-resistant pancreatic cancer (CPC) cell lines through multiple mechanisms, which exhibited superior anticancer efficacy compared with gemcitabine. However, toxicity due to non-specific exposure to healthy tissues hindered its clinical translation. Herei...

2017
Meng-Dan Xu Shu-Ling Liu Yi-Zhong Feng Qiang Liu Meng Shen Qiaoming Zhi Zeyi Liu Dong-Mei Gu Jie Yu Liu-Mei Shou Fei-Ran Gong Qi Zhu Weiming Duan Kai Chen Junning Zhang Meng-Yao Wu Min Tao Wei Li

Squamous cell carcinoma (SCC) of pancreas is a rare histotype of pancreatic ductal carcinoma which is distinct from pancreatic adenocarcinoma (AC). Although there are standard treatments for pancreatic AC, no precise therapies exist for pancreatic SCC. Here, we screened 1033 cases of pancreatic cancer and identified 2 cases of pure SCC, which were pathologically diagnosed on the basis of findin...

2017
Joo Mi Yi Eun-Jin Kang Hyun-Mi Kwon Jin-Han Bae Keunsoo Kang Nita Ahuja Kwangmo Yang

Altered expression of microRNAs has been strongly implicated in human cancers, and growing evidence is emerging that a number of miRNAs are downregulated in cancer associated with CpG island hypermethylation. Although pancreatic cancer is one of the most malignant human cancers, the roles of miRNAs underlying the tumorigenesis of pancreatic cancer are still poorly understood. In the present stu...

2014
Ethan V. Abel Edward J. Kim Jingjiang Wu Mark Hynes Filip Bednar Erica Proctor Lidong Wang Michele L. Dziubinski Diane M. Simeone

BACKGROUND Pancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer cells that have the capacity to initiate and propagate tumor formation. However, the mechanisms by which pancreatic CSCs are maintained are not well understood or characterized. METHODS Expression of Notch receptors, ligands, and Notch signaling target genes was quantitated in the CSC and non-C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید